Biotechnology News and Research

RSS

More than 100 million doses of influenza vaccine available this year in the United States

Despite an Aug. 26 announcement that some doses of influenza vaccine to the United States have been delayed, the Centers for Disease Control and Prevention said the effects of the delay will be minimal - and physicians do not need to order more doses.

5 Sep 2004

World needs to commit more resources to treat people infected with HIV

Leaders of the International AIDS Vaccine Initiative (IAVI) have stressed that as the world commits more resources to treat people infected with HIV, it must also intensify efforts to develop a vaccine to prevent new infections and stop the continuing spread of the virus.

2 Sep 2004

Researchers accurately pinpoint the types of lymphoma, Hodgkins or non-Hodgkins

“There are many types and subtypes of lymphoma, some of which are easy to detect, but many that are very difficult to identify,” says Antonio Giordano, M.D., Ph.D., director of the Sbarro Institute at Temple and one of the study’s principal investigators.

1 Sep 2004

Scientists to tackle the most common cause of diarrhoea world-wide with DNA sequencing

Returning holidaymakers may be comforted to know that travellers' diarrhoea could be a thing of the past. Scientists at the University of Birmingham's Medical School are set to sequence the DNA of the bacterium: this will identify causes of illness and point to better cures.

31 Aug 2004

Kiwis reverse heart disease in diabetics

New Zealand biopharmaceutical company Protemix Corporation has announced the discovery of a treatment which appears to reverse heart disease in people suffering from diabetes and may lead to a more effective intervention in a major cause of death worldwide.

30 Aug 2004

Attention deficit/hyperactivity disorder high among Chernobyl children

In an extensive study of children exposed to varying levels of fallout from the 1986 Chernobyl Nuclear Power Plant accident, Israeli researchers have found that Attention Deficit/Hyperactivity Disorder (ADHD) scores are higher among those who were in-utero at the time of the accident -- regardless of their actual level of radiation exposure.

26 Aug 2004

StemCells issued U.S. stem cell patent

StemCells, Inc. has announced that the Company has been issued U.S. patent 6,777,233 for work done at the Company covering composition of matter claims for the human neural stem cell.

23 Aug 2004

Research offers hope for the millions of diabetics worldwide who take insulin injections

University of Toronto researchers have identified individual cells in the adult mouse pancreas capable of generating insulin-producing beta cells.

22 Aug 2004

Existing hepatitis drug could lead to the development of new drugs for the treatment of anthrax

Thanks to new screening tools, and some luck, researchers at the University of Chicago have discovered three unrelated compounds that inhibit the two toxins – edema factor and lethal factor -- that have made anthrax one of the most feared of potential bioterror agents.

21 Aug 2004

Antibodies produced by shark immune systems could be used to detect human pathogens

A recent discovery shows that antibodies produced by shark immune systems could be used to detect a range of human pathogens some of which have the potential to be used as biological warfare agents.

20 Aug 2004

Major expansion of research and development facilities at The Centre for Life

The Centre for Life has unveiled plans which will help develop Newcastle’s position as a world leader in the fields of innovation and research.

18 Aug 2004

Scientists have successfully filmed individual cells migrating within a functioning lymph node

The researchers hope to gain a deeper understanding of how our immune system functions from their detailed study of lymph node processes.

17 Aug 2004

Device to warn astronauts about the presence of harmful compounds inside spacecraft

U.S. Rep. John Duncan presented a check for $1.48 million to the University of Tennessee Center for Environmental Biotechnology Wednesday.

13 Aug 2004

Ways to economically recover recombinant proteins from transgenic tobacco

The economics of producing biopharmaceuticals from transgenic plants such as tobacco is still a roadblock to producing large quantities of urgently needed medicines, especially for people in underdeveloped nations.

12 Aug 2004

New biotech alliance to focus on diseases of nerve injury and pain

NeuroTargets Ltd, a discovery-led biotechnology company ‘spun-out’ from the University of Bristol, has formed an exciting new alliance with BioFocus plc, a world leader in collaborative drug discovery, to focus on diseases of nerve injury and pain.

11 Aug 2004

Clinical trial of lipase inhibitor for the treatment of obesity

Peptimmune, Inc. a privately held biotechnology company, announced that physicians have treated the first participant in a clinical trial to evaluate the safety, tolerability and pharmacokinetics of GT389-255, a lipase inhibitor conjugated to a fat binding polymer for the treatment of obesity.

9 Aug 2004

Total global market for oligonucleotides is likely to grow from USD 340.0 million in 2003 to USD 776.0 million in 2010

Poised on the brink of phenomenal growth, the oligonucleotides market offers a plethora of opportunities to the enterprising investor. Recent analysis by Frost & Sullivan estimates that the total global market for oligonucleotides is likely to grow from USD 340.0 million in 2003 to USD 776.0 million in 2010.

9 Aug 2004

Cyntellect issued patent covering LaserFect(TM) technology

Cyntellect a privately-held biotechnology company, has announced the issuance of U.S. Patent No. 6,753,161 covering the Company's LaserFect(TM) technology.

6 Aug 2004

Zyomyx issued five new biotech patents

Zyomyx a privately held biotechnology company, has announced that the United States Patent and Trademark Office issued five new patents to the Company. With these additions, Zyomyx has further strengthened its proprietary position in the area of protein biochip technology development and commercialization.

6 Aug 2004

Automated science speeds solution of Human Genome data

Scientists in Argonne's Biosciences Division are automating and accelerating the complex processes that coax a protein to reveal its structure so they can learn the role Nature assigned it.

6 Aug 2004

Biotechnology News and Research

More than 100 million doses of influenza vaccine available this year in the United States

World needs to commit more resources to treat people infected with HIV

Researchers accurately pinpoint the types of lymphoma, Hodgkins or non-Hodgkins

Scientists to tackle the most common cause of diarrhoea world-wide with DNA sequencing

Kiwis reverse heart disease in diabetics

Attention deficit/hyperactivity disorder high among Chernobyl children

StemCells issued U.S. stem cell patent

Research offers hope for the millions of diabetics worldwide who take insulin injections

Existing hepatitis drug could lead to the development of new drugs for the treatment of anthrax

Antibodies produced by shark immune systems could be used to detect human pathogens

Major expansion of research and development facilities at The Centre for Life

Scientists have successfully filmed individual cells migrating within a functioning lymph node

Device to warn astronauts about the presence of harmful compounds inside spacecraft

Ways to economically recover recombinant proteins from transgenic tobacco

New biotech alliance to focus on diseases of nerve injury and pain

Clinical trial of lipase inhibitor for the treatment of obesity

Total global market for oligonucleotides is likely to grow from USD 340.0 million in 2003 to USD 776.0 million in 2010

Cyntellect issued patent covering LaserFect(TM) technology

Zyomyx issued five new biotech patents

Automated science speeds solution of Human Genome data

Biotechnology eBook

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News